WO2006121521A3 - Implants pour tissus mous, agents prevenant la formation de cicatrices et compositions therapeutiques - Google Patents

Implants pour tissus mous, agents prevenant la formation de cicatrices et compositions therapeutiques Download PDF

Info

Publication number
WO2006121521A3
WO2006121521A3 PCT/US2006/011690 US2006011690W WO2006121521A3 WO 2006121521 A3 WO2006121521 A3 WO 2006121521A3 US 2006011690 W US2006011690 W US 2006011690W WO 2006121521 A3 WO2006121521 A3 WO 2006121521A3
Authority
WO
WIPO (PCT)
Prior art keywords
soft tissue
therapeutic compositions
tissue implants
scarring agents
scarring
Prior art date
Application number
PCT/US2006/011690
Other languages
English (en)
Other versions
WO2006121521A2 (fr
Inventor
William L Hunter
Philip M Toleikis
David M Gravett
Arpita Maiti
Richard T Liggins
Aniko Takacs-Cox
Rui Avelar
Pierre E Signore
Troy A E Loss
Anne Hutchinson
Gaye Mcdonald-Jones
Fara Lakhani
Original Assignee
Angiotech Int Ag
William L Hunter
Philip M Toleikis
David M Gravett
Arpita Maiti
Richard T Liggins
Aniko Takacs-Cox
Rui Avelar
Pierre E Signore
Troy A E Loss
Anne Hutchinson
Gaye Mcdonald-Jones
Fara Lakhani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiotech Int Ag, William L Hunter, Philip M Toleikis, David M Gravett, Arpita Maiti, Richard T Liggins, Aniko Takacs-Cox, Rui Avelar, Pierre E Signore, Troy A E Loss, Anne Hutchinson, Gaye Mcdonald-Jones, Fara Lakhani filed Critical Angiotech Int Ag
Publication of WO2006121521A2 publication Critical patent/WO2006121521A2/fr
Publication of WO2006121521A3 publication Critical patent/WO2006121521A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

On utilise des implants pour tissus mous (p. ex des implants pour la poitrine, pectoraux, pour le menton, faciaux, pour les lèvres) en combinaison avec un agent empêchant la formation de cicatrices susceptibles de se développer lorsque l'implant est placé dans l'animal.
PCT/US2006/011690 2005-05-10 2006-03-31 Implants pour tissus mous, agents prevenant la formation de cicatrices et compositions therapeutiques WO2006121521A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67929305P 2005-05-10 2005-05-10
US67996205P 2005-05-10 2005-05-10
US60/679,293 2005-05-10
US60/679,962 2005-05-10

Publications (2)

Publication Number Publication Date
WO2006121521A2 WO2006121521A2 (fr) 2006-11-16
WO2006121521A3 true WO2006121521A3 (fr) 2007-01-11

Family

ID=37397028

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/011690 WO2006121521A2 (fr) 2005-05-10 2006-03-31 Implants pour tissus mous, agents prevenant la formation de cicatrices et compositions therapeutiques

Country Status (1)

Country Link
WO (1) WO2006121521A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
WO2020082051A1 (fr) * 2018-10-19 2020-04-23 Regents Of The University Of Minnesota Induction de tolérance aux greffes avec un vaccin tolérant un carbodiimide traité

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175703A1 (en) * 2003-11-20 2005-08-11 Angiotech International Ag Polymer compositions and methods for their use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175703A1 (en) * 2003-11-20 2005-08-11 Angiotech International Ag Polymer compositions and methods for their use

Also Published As

Publication number Publication date
WO2006121521A2 (fr) 2006-11-16

Similar Documents

Publication Publication Date Title
WO2007041677A3 (fr) Implants de tissus mous et compositions de médicaments combinés, et leur utilisation
WO2005051232A3 (fr) Implants de tissus mous et agents anti-cicatrisants
WO2005065079A3 (fr) Implants medicaux et agents inducteurs de fibrose
WO2006121518A3 (fr) Dispositifs electriques, agents prevenant la formation de cicatrices et compositions therapeutiques
WO2001070132A3 (fr) Microspheres injectables et gonflables conçues pour une augmentation dermique
AU2003273276A8 (en) Methods and compositions for the preservation of cells, tissues or organs in the vitreous state
EP1575528A4 (fr) Cytokines de protection tissulaire permettant la protection, la restauration et la stimulation de cellules, tissus et organes sensibles
WO2004021968A3 (fr) Solution destinee a une application ungueale et peri-ungueale
AP1913A (en) Substituted benzazoles and use thereof as raf kinase inhibitors
WO2009017646A3 (fr) Compositions et procédés pour une augmentation de tissu mou
WO2003087303A3 (fr) Composites tissulaires et utilisations
MXPA03005893A (es) Proteccion, restauracion, y mejora de celulas, tejidos y organos que responden a la eritropoyetina.
NO2014010I2 (fr)
ZA200602379B (en) Soft tissue implants and anti-scarring agents
EP1676512A3 (fr) Articles pour traitement de la peau et méthodes
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
EP2433593A3 (fr) Dispositifs, systèmes et procédés pour fixer un tissu dans les régions corporelles, telles que le conduit pharyngien
EP1631271A4 (fr) Methodes et compositions pour distribuer des butanes catecholiques pour le traitement de tumeurs
WO2007127273A3 (fr) Procédés et compositions permettant de modifier la fonction cellulaire
TW200637570A (en) Oral care compositions comprising a eucalyptus extract
MX2007000418A (es) Metodos y reactivos para tratar abejas para acaros parasiticos.
WO2007084614A3 (fr) Préparation pour croissance capillaire
SI1546088T1 (sl) Spojine za uporabo v zdravljenju avtoimunskih bolezni, imunoalergijskih bolezni in zavrnitve transpalantata organa ali tkiva
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
EP1535514A4 (fr) Composition permettant de proteger un organe, un tissu ou des cellules et son procede d'utilisation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 06758226

Country of ref document: EP

Kind code of ref document: A2